Back to Search
Start Over
Intermittent high dose (pulsatile) erlotinib for EGFRvIII mutant recurrent malignant gliomas: A pilot clinical trial
- Authors :
- Lassman, A.
Grommes, C.
Panageas, K.
Iwamoto, F.
Lisa DeAngelis
Kaley, T.
Gavrilovic, I.
Pentsova, E.
Omuro, A.
Corpuz, C.
Briggs, S.
Otap, D.
Qin, W.
Cross, J.
Mellinghoff, I.
- Source :
- Memorial Sloan Kettering Cancer Center
Details
- Database :
- OpenAIRE
- Journal :
- Memorial Sloan Kettering Cancer Center
- Accession number :
- edsair.dedup.wf.001..89844eb237f2c755f851eb0a3d11a218